Transaction · 0001628280-26-000209

Burnett Patrick

Burnett Patrick, SR, reported an open-market or private sale at Arcutis Biotherapeutics, Inc. involving 541.000000 shares for an estimated $15586.21. Reported holdings after the transaction were 97766.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SSR
ARQTArcutis Biotherapeutics, Inc.
Filing timeJan 02
Trade dateDec 31, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$29.00
Pre-filing
1mo ago +4.7%1w ago +4.7%1d ago +4.7%
Returns since
7d +0.0%30d +0.0%90d -16.9%180d -10.9%1y -18.1%

ARQT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ARQT since 2026-01-02Filed 244 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-000209
Common Stock
Transaction date
Dec 31, 2025
Filed Jan 02, 2026, 11:12 PM · 2d delay
Shares
541 sh
$2.88k per share
Estimated value
-$1.55M
Computed from shares × price
Holdings after
97.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units, granted…

  2. F2

    The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $28.08 to $29.08, inclusive. The Reporting Person hereby undertake…

  3. F3

    The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $29.0829 to $29.57, inclusive. The Reporting Person hereby underta…

Original filing · 0001628280-26-000209
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ARQT